SBC Medical Group Holdings Incorporated — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$40M↓-10.9%$14M↑+117.2%32.5%
2025-09-30$43M↓-18.3%$13M↑+352.7%36.6%
2025-06-30$43M↓-18.3%$2M↓-86.9%33.6%
2025-03-31$47M↓-13.6%$21M↑+14.6%51.1%
2024-12-31$44M↓-28.8%$7M↓-54.4%10.6%
2024-09-30$53M↑+12.3%$3M↓-66.1%26.1%
2024-06-30$53M$19M↑+88.3%51.4%
2024-03-31$55M$19M↑+192.2%44.6%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$40M
↓-10.9% -$5M YoY
Net Income
$9M
↑+80.8% +$4M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 15 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-3.1pts
73.1%
Operating Margin↑+21.9pts
32.5%
Net Margin↑+21.2pts
35.9%

Go deeper